Adsorption of human blood plasma on nanodiamond and its influence on activated partial thromboplastin time

被引:29
|
作者
Mona, J. [1 ]
Kuo, C-J [1 ]
Perevedentseva, E. [1 ,2 ]
Priezzhev, A. V. [3 ]
Cheng, C. -L. [1 ]
机构
[1] Natl Dong Hwa Univ, Dept Phys, Shoufeng 97401, Hualien, Taiwan
[2] Rus Acad Sci, PN Lebedev Phys Inst, Moscow 119991, Russia
[3] Moscow MV Lomonosov State Univ, Dept Phys, Ctr Int Laser, Moscow 119991, Russia
关键词
Nanodiamond; Human blood plasma; Adsorption; Blood coagulation; FLUORESCENT NANODIAMONDS; PROTEIN ADSORPTION; CARBON NANOTUBES; DIAMOND; NANOPARTICLES; PLATELETS;
D O I
10.1016/j.diamond.2013.08.001
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Ever increasing use of engineered nanodiamond (ND) into the human blood for various biomedical studies and applications has increased the demand to thoroughly understand the interaction of NDs with blood and its effect on blood coagulation. Here, we report on the study of adsorption of human blood plasma on various sized carboxylated nanodiamonds (cNDs) using UV/visible spectroscopy and Fourier transform infrared spectroscopy (FIR). The adsorption of human blood plasma on 5 nm and 100 nm sized cNDs is confirmed from UV/visible spectra. FTIR shows minor change in the shape of amide 1 absorption peak (1600-1700 cm(-1)) indicating that the protein secondary structure remains unaffected for human blood plasma. The influence of cNDs on the blood coagulation has been estimated using Activated Partial Thromboplastin Time (APTT) test. The APTT test is one of the standard tests used to investigate the efficacy of the intrinsic pathways of coagulation. The APTT test results indicate that 5 and 100 nm cNDs with various concentrations (10-500 mu g/ml) do not show delay in time when coagulation was initiated through the intrinsic pathway. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [11] EFFECT OF FREEZING HEPARINIZED PLASMA ON ACTIVATED PARTIAL THROMBOPLASTIN TIME
    MORIN, RJ
    RICHARDS, D
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1974, 61 (06) : 823 - 827
  • [12] Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration
    Koerber, JM
    Smythe, MA
    Begle, RL
    Mattson, JC
    Kershaw, BP
    Westley, SJ
    [J]. PHARMACOTHERAPY, 1999, 19 (08): : 922 - 931
  • [13] Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma
    Mischke, R
    Wolling, H
    [J]. HAEMOSTASIS, 2000, 30 (03) : 123 - 130
  • [14] Influence of rivaroxaban on different activated partial thromboplastin time assays
    Harenberg, J.
    Giese, C.
    Erdle, S.
    Marx, S.
    Weiss, C.
    Kraemer, R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 364 - 364
  • [15] Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation
    Sobas, F
    Hanss, M
    Ffrench, P
    Trzeciak, MC
    Dechavanne, M
    Négrier, C
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (01) : 61 - 68
  • [16] THE ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESPONSE
    SUCHMAN, AL
    GRINER, PF
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (04) : 627 - 627
  • [17] ACTIVATED PARTIAL THROMBOPLASTIN TIME - REPLY
    HIRSH, J
    GALLUS, AS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (26): : 1410 - 1410
  • [18] ERRONEOUS ACTIVATED PARTIAL THROMBOPLASTIN TIME
    OWEN, J
    PAYNE, E
    CARSTAIRS, K
    [J]. ANNALS OF INTERNAL MEDICINE, 1978, 89 (01) : 146 - 146
  • [19] Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays
    Yao, Ke
    Zhang, Lingyun
    Zhou, Hang
    Tang, Ning
    Li, Dengju
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (01): : 22 - 26
  • [20] Activated partial thromboplastin time evaluation
    Spinler, SA
    [J]. PHARMACOTHERAPY, 2001, 21 (03): : 363 - 364